For patients with cataracts and astigmatism there is the ACRYSOF® Toric lens, which corrects for both conditions simultaneously.
Approximately 15% to 29% of cataract patients have more than one diopter of astigmatism which can prevent them from achieving the visual acuity that leads to the spectacle freedom they desire. A new option in astigmatic correction is the Alcon Acrysof Toric IOL which is designed to focus the light otherwise scattered by corneal astigmatism and thereby minimize image distortion. Based on the results of the FDA clinical trial, the Acrysof Toric IOL represents an effective option for treating astigmatism.
Cataract surgery with the implantation of the Acrysof Toric IOL provides an attractive alternative for cataract patients that may reduce their dependence on spectacles for distance vision.